amitriptyline has been researched along with Experimental Mammary Neoplasms in 1 studies
Amitriptyline: Tricyclic antidepressant with anticholinergic and sedative properties. It appears to prevent the re-uptake of norepinephrine and serotonin at nerve terminals, thus potentiating the action of these neurotransmitters. Amitriptyline also appears to antagonize cholinergic and alpha-1 adrenergic responses to bioactive amines.
amitriptyline : An organic tricyclic compound that is 10,11-dihydro-5H-dibenzo[a,d][7]annulene substituted by a 3-(dimethylamino)propylidene group at position 5.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brandes, LJ | 1 |
| Arron, RJ | 1 |
| Bogdanovic, RP | 1 |
| Tong, J | 1 |
| Zaborniak, CL | 1 |
| Hogg, GR | 1 |
| Warrington, RC | 1 |
| Fang, W | 1 |
| LaBella, FS | 1 |
1 other study available for amitriptyline and Experimental Mammary Neoplasms
| Article | Year |
|---|---|
Stimulation of malignant growth in rodents by antidepressant drugs at clinically relevant doses.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Amitriptyline; Animals; Antidepressive Agents; DNA; Fluoxetine; Ly | 1992 |